S&P 500   0.57 (+0.00%)
DOW   0.57 (+0.00%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+0.00%)
DOW   0.57 (+0.00%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+0.00%)
DOW   0.57 (+0.00%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+0.00%)
DOW   0.57 (+0.00%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

Bloom Burton Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Bloom Burton. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Bloom Burton.

CompanyDateActionBrokerageRatingPrice TargetImpact on PriceActions
HLS
HLS Therapeutics
7/21/2020Upgraded byBloom BurtonAccumulate -> BuyN/A    
Knight Therapeutics logo
GUD
Knight Therapeutics
6/29/2020Downgraded byBloom BurtonBuy -> AccumulateN/A    
Zymeworks logo
ZYME
Zymeworks
6/14/2020Reiterated byBloom BurtonBuyLow    
ESSA Pharma logo
EPIX
ESSA Pharma
5/24/2020Reiterated byBloom BurtonBuy $9.00High    
Cipher Pharmaceuticals logo
CPH
Cipher Pharmaceuticals
5/8/2020Upgraded byBloom BurtonHold -> AccumulateN/A    
HLS
HLS Therapeutics
3/31/2020Downgraded byBloom BurtonBuy -> AccumulateN/A    
Aurinia Pharmaceuticals logo
AUPH
Aurinia Pharmaceuticals
3/19/2020Reiterated byBloom BurtonBuy $23.00Low    
NRI
Nuvo Pharmaceuticals
11/12/2019Upgraded byBloom BurtonHold -> BuyN/A    
Knight Therapeutics logo
GUD
Knight Therapeutics
10/22/2019Upgraded byBloom BurtonAccumulate -> BuyN/A    
AUP
Aurinia Pharmaceuticals
10/2/2019Reiterated byBloom BurtonBuyN/A    
Aurinia Pharmaceuticals logo
AUPH
Aurinia Pharmaceuticals
10/2/2019Reiterated byBloom BurtonBuyLow    
BLU
Bellus Health
9/6/2019Reiterated byBloom BurtonBuyLow    
Cipher Pharmaceuticals logo
CPH
Cipher Pharmaceuticals
8/12/2019Reiterated byBloom BurtonHoldN/A    
CRH Medical logo
CRHM
CRH Medical
8/1/2019Upgraded byBloom BurtonAccumulate -> BuyN/A    
CRH Medical logo
CRH
CRH Medical
8/1/2019Upgraded byBloom BurtonAccumulate -> BuyN/A    
CRHM
CRH Medical
8/1/2019Upgraded byBloom BurtonAccumulate -> BuyMedium    
NRI
Nuvo Pharmaceuticals
5/16/2019Downgraded byBloom BurtonBuy -> HoldN/A    
NRI
Nuvo Pharmaceuticals
4/1/2019Reiterated byBloom BurtonBuyN/A    
Cipher Pharmaceuticals logo
CPH
Cipher Pharmaceuticals
3/20/2019Reiterated byBloom BurtonBuyN/A    
CXRXF
Advanz Pharma
3/15/2019Reiterated byBloom BurtonHoldLow    
Novelion Therapeutics logo
NVLN
Novelion Therapeutics
11/14/2018Downgraded byBloom BurtonAccumulate -> HoldMedium    
Knight Therapeutics logo
GUD
Knight Therapeutics
11/9/2018Reiterated byBloom BurtonAccumulateN/A    
NRI
Nuvo Pharmaceuticals
3/26/2018Upgraded byBloom BurtonAccumulate -> BuyN/A    
ESSA Pharma logo
EPIX
ESSA Pharma
1/18/2018Upgraded byBloom BurtonHold -> BuyHigh    
NRI
Nuvo Pharmaceuticals
11/3/2017Downgraded byBloom BurtonBuy -> AccumulateN/A    
ESSA Pharma logo
EPIX
ESSA Pharma
9/12/2017Downgraded byBloom BurtonBuy -> HoldLow    
Cipher Pharmaceuticals logo
CPH
Cipher Pharmaceuticals
8/14/2017Downgraded byBloom BurtonBuy -> HoldN/A    
CRH Medical logo
CRH
CRH Medical
7/14/2017Downgraded byBloom BurtonBuy -> AccumulateN/A    
CRH Medical logo
CRHM
CRH Medical
7/14/2017Downgraded byBloom BurtonBuy -> AccumulateN/A    
Novelion Therapeutics logo
NVLN
Novelion Therapeutics
6/19/2017Reiterated byBloom BurtonAccumulateLow    
ESSA Pharma logo
EPIX
ESSA Pharma
5/18/2017Reiterated byBloom BurtonBuyLow    
NRI
Nuvo Pharmaceuticals
5/15/2017Upgraded byBloom BurtonHold -> BuyN/A    
Cipher Pharmaceuticals logo
CPH
Cipher Pharmaceuticals
5/12/2017Upgraded byBloom BurtonHold -> BuyN/A    
NRI
Nuvo Pharmaceuticals
5/9/2017Downgraded byBloom BurtonAccumulate -> HoldN/A    
CRH Medical logo
CRH
CRH Medical
2/24/2017Downgraded byBloom BurtonBuy -> AccumulateN/A    
Cipher Pharmaceuticals logo
CPH
Cipher Pharmaceuticals
2/13/2017Reiterated byBloom BurtonHoldN/A    
Arbutus Biopharma logo
ABUS
Arbutus Biopharma
1/9/2017Upgraded byBloom BurtonAccumulate -> BuyN/A    
Xenon Pharmaceuticals logo
XENE
Xenon Pharmaceuticals
12/22/2016Initiated byBloom BurtonBuy $14.50N/A    
Arbutus Biopharma logo
ABUS
Arbutus Biopharma
12/14/2016Reiterated byBloom BurtonAccumulateN/A    
Knight Therapeutics logo
GUD
Knight Therapeutics
11/10/2016Reiterated byBloom BurtonAccumulateN/A    
Trillium Therapeutics logo
TRIL
Trillium Therapeutics
11/4/2016Reiterated byBloom BurtonBuyN/A    
AUP
Aurinia Pharmaceuticals
11/4/2016Reiterated byBloom BurtonBuyN/A    
Aurinia Pharmaceuticals logo
AUPH
Aurinia Pharmaceuticals
11/4/2016Reiterated byBloom BurtonBuyN/A    
NRI
Nuvo Pharmaceuticals
11/2/2016Reiterated byBloom BurtonAccumulateN/A    
CRH Medical logo
CRH
CRH Medical
10/28/2016Reiterated byBloom BurtonBuyN/A    
Achieve Life Sciences logo
ACHV
Achieve Life Sciences
5/3/2013Target Raised byBloom BurtonBuy$4,000.00 -> $5,000.00N/A    
Achieve Life Sciences logo
ACHV
Achieve Life Sciences
3/8/2013Target Raised byBloom Burton$3,600.00 -> $4,000.00N/A    
ONC
Oncolytics Biotech
12/18/2012Downgraded byBloom BurtonBuy -> HoldN/A    
Theratechnologies logo
THERF
Theratechnologies
6/25/2012Downgraded byBloom BurtonHold -> Sell$2.50 -> $0.75N/A    
Achieve Life Sciences logo
ACHV
Achieve Life Sciences
5/4/2012Target Lowered byBloom BurtonBuy$3,800.00 -> $3,600.00N/A    

This page was last refreshed on Tuesday at 12:43 AM ET.

MarketBeat Community Rating for Bloom Burton

Community Ranking:  1.9 out of 5 (star half star)
Outperform Votes:  17,671 (Vote Outperform)
Underperform Votes:  28,148 (Vote Underperform)
Total Votes:  45,819
MarketBeat's community ratings are surveys of what our community members think about Bloom Burton and other research firms. Vote "Outperform" if you believe Bloom Burton's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Bloom Burton's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.